Michael David Garrison
CIK 1944816 · EVP & Pres Med.Essntl&BioPharm · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.33M
Companies
2
Total Filings
29
Lifetime Open-Market Net
-$2.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDX | EVP & Pres Med.Essntl&BioPharm | 13,172 | $176.86 | $2.33M | -$2.91M | 16 | 2026-06-25 |
| BECTON DICKINSON & CO (BDXB) Delisted | EVP & President Medical | 6,457 | $48.16 | $311.0K | $0 | 2 | 2023-03-03 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-18 | BDX | Notice (144) | −1,185 | -$214.4K | EDGAR |
| 2025-04-10 | BDX | Sell (S) | −479 | -$94.5K | EDGAR |
| 2025-04-09 | BDX | Notice (144) | −479 | -$96.2K | EDGAR |
| 2025-03-04 | BDX | Tax (F) | −178 | $0 | EDGAR |
| 2025-01-21 | BDX | Sell (S) | −597 | -$141.2K | EDGAR |
| 2025-01-17 | BDX | Notice (144) | −597 | -$141.1K | EDGAR |
| 2024-12-20 | BDX | Sell (S) | −2,838 | -$633.8K | EDGAR |
| 2024-12-19 | BDX | Notice (144) | −2,838 | -$636.0K | EDGAR |
| 2024-11-29 | BDX | Mixed | +3,598 | $0 | EDGAR |
| 2024-05-01 | BDX | Sell (S) | −1,715 | -$399.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.